NCT01164098View on ClinicalTrials.gov

Rituximab to Prevent Recurrence of Proteinuria

PHASE3TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

FSGSProteinuria

Interventions

DRUG

Rituximab

Induction therapy

Trial Locations (1)

33136

University of Miami, Miami

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

George W. Burke

OTHER